Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
Clinical trial NCT07187167 · RECRUITING
Trial details
- NCT number
- NCT07187167
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-12
- Primary completion
- 2027-04-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.